Common TitleSofosbuvir-Velpatasvir in Patients with Compensated Cirrhosis and HCV Genotype 3 (Spain)
Official Title Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Phase Phase II
ClinicalTrials.gov NCT02781558
Treatments
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
Tradename:EpclusaOther Names:SOF-VELClass:FDA-ApprovedFunding
IndustryGilead Sciences